高端四價流感疫苗

Land: Taiwan

Språk: kinesisk

Kilde: 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

Aktiv ingrediens:

A/Victoria/2570/2019 (H1N1);;A/Hong Kong/2671/2019 (H3N2);;B/Washington/02/2019 (B/Victoria lineage);;B/Phuket/3073/2013 (B/Yamagata lineage)

Tilgjengelig fra:

高端疫苗生物製劑股份有限公司 新竹縣竹北市生醫三路68號 (53943057)

ATC-kode:

J07BB02

Legemiddelform:

無菌懸浮注射液

Sammensetning:

A/Victoria/2570/2019 (H1N1) (8012002530) MCG; B/Phuket/3073/2013 (B/Yamagata lineage) (8012006241) MCG; B/Washington/02/2019 (B/Victoria lineage) (8012006831) MCG; A/Hong Kong/2671/2019 (H3N2) (8012017060) MCG

Enheter i pakken:

包裝

Klasse:

菌　疫

Resept typen:

須由醫師處方使用

Produsert av:

GC Biopharma Corporation, HWASUN PLANT 40 Sandan-gil, Hwasun-eup, Hwasun-gun, Jeollanam-do, Republic of Korea KR

Terapeutisk område:

influenza, inactivated, split virus or surface antigen

Indikasjoner:

適用於3歲以上兒童及成人之主動免疫接種，藉以預防此疫苗所涵蓋之兩種A型流感病毒及兩種B型流感病毒所引起的流行性感冒。

Produkt oppsummering:

有效日期: 2028/03/13; 英文品名: MVC FLU Quadrivalent pre-filled syringe injection

Autorisasjon dato:

2023-03-13